logo dark logo light logo
  • Home
  • About Us
    • Background
    • Investment Strategy
    • Team
  • Portfolio
  • News
  • Contact
  • 中文
  • Investor Login
mobile-logo
  • Home
  • About Us
    • Background
    • Investment Strategy
    • Team
  • Portfolio
  • News
  • Contact
  • 中文
  • Investor Login
We are Company Builders

We are Company Builders

Identifying, incubating and growing future industry leaders in life sciences.

We are Industry Veterans

We are Industry Veterans

Capturing evolving healthcare trends and emerging cutting-edge innovations

We are Preferred Partners

We are Preferred Partners

Connecting companies with extensive network and resources globally and in China

  • Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts

    ...

    April 14, 2026
  • Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies

    ...

    April 10, 2026
  • NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer

    ...

    April 7, 2026
All news

899 Halei Road, Building B, 4/F, Pudong New Area, Shanghai 201203, P.R. China
Phone: +86 21 6163 2598 | Fax: +86 21 6163 2570 | Email: info@quancapital.com

© Quan Capital. All rights reserved. Website Development. 沪ICP备18031693号-1